On Mar. 20, 2026, Novartis announced an agreement with Synnovation Therapeutics, to acquire SNV4818, a pan-mutant‑selective PI3Kα inhibitor,…
On Mar. 19, 2026, The U.S. Food and Drug Administration approved a 7.2-milligram dose of Danish drugmaker Novo…
On Mar. 19, 2026, a nationwide STAT survey of federally funded researchers reveals that, a year after Donald…
On Mar. 18, 2026, the National Institutes of Health (NIH) announced more than $150 million to develop and…
On Mar. 16, 2026, investigators from Mass General Brigham announce they have built metabolic polygenic risk scores (PRS) for predicting…
On Mar. 13, 2026, ImmunityBio announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a…
On Mar. 12, 2026, Mass General Brigham (MGB) announced it has received a $50 million gift that will…
On Mar. 11, 2026, taking a step towards developing genetic therapies at scale, researchers from Mass General Brigham…
On Mar. 8, 2026, a new statewide spatial analysis of Alzheimer’s disease and related dementias (ADRD) has uncovered…
On Mar. 6, 2026, Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has approved…
On Mar. 6, 2026, Sumitomo Pharma announce it has obtained conditional and time‑limited approval in Japan for the…
On Feb. 26, 2026, A University of California Davis Health research team has safely performed the world’s first spina…
On Feb. 26, 2026, Novartis announced it has settled a lawsuit by the estate of Henrietta Lacks that…
On Feb. 23, 2026, Gilead Sciences announced it will buy cancer therapy partner Arcellx for an implied equity…
On Feb. 19, 2026, Phil and Penny Knight announced they have given a second transformational gift of $75 million…
On Feb. 18, 2026, researchers at SANKEN, University of Osaka announced using a nanoreactor to produce pores that…
On Feb. 18, 2026, Johnson & Johnson announced announced a more than $1 billion investment in a next…
On Feb. 17, 2026, Fred Hutch Cancer Center scientists announced reaching a crucial milestone in blocking Epstein Barr…
On Feb. 17, 2026, the Department of Energy’s (DOE) Pacific Northwest National Laboratory (PNNL) announces it has joined…
On Feb. 9, 2026, Eli Lilly and Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in…
On Feb. 7, 2026, Genentech, a member of the Roche Group, announced late-breaking data from the Phase III…
On Feb. 6, 2026, A study by federal and state health researchers indicates invasive Escherichia coli infections are…
On Feb. 6, 2026, Novartis broke ground on a new, state-of-the-art global Biomedical Research center in San Diego,…
On Feb. 6, 2026, a study led by researchers at Oxford Population Health reported that statins do not…
On Feb. 4, 2026, researchers from UT Southwestern Medical Center report that an experimental pill called enlicitide slashed…
On Feb. 4, 2026, Keck Medicine of the University of Southern California (USC) announced it is conducting an early phase clinical…
On Jan. 30, 2026, Eli Lilly announced plans to invest more than $3.5 billion in a new manufacturing…
On Jan. 28, 2026, U.S. drugmaker Eli Lilly announces signing an agreement worth up to $1.12 billion with…
On Jan. 28, 2026, the U.S. Environmental Protection Agency (EPA) launched the first step of its expedited review…
On Jan. 28, 2026, researchers at Google DeepMind have unveiled their latest artificial intelligence tool and claimed it…